Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

KeyNeurotek AG

KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment of acute and chronic neurodegenerative disorders of the Central Nervous System (e.g. stroke and Alzheimer disease), the company merges superior expertise in neurobiology, preclinical and clinical drug development, medicinal chemistry and in silico/wet chemistry. KeyNeurotek has established efficient platform technologies for a tissue-based and disease-related functional screening ex and in vivo in order to catalyze the identification and development of highly promising drug candidates. KeyNeurotek's exclusive and HTS-compatible TELOMICSTM ex vivo Robotics represents the first setup for tissue-based high content screening world-wide and the technological basis of our approach to drug development.


Contact Details:
ZENIT-Technology Park Leipziger Str. 44
Magdeburg
D-39120
Germany
Tel:49 (0) 3 91 / 6 11 72 20
Fax:49 (0) 3 91 / 6 11 72 21
Email:info@keyneurotek.de
WWW:

www.keyneurotek.de/




Recent Publications by KeyNeurotek AG:

Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.
OBJECTIVE: The aim of the present work was the detection of Mitochondrial...
28th April, 2006
KeyNeurotek AG, ZENIT Technology Park, Magdeburg, Germany. Ann Neurol. 2006 Feb;59(2):407-11.
DOI Direct Link

Press Releases on KeyNeurotek AG:

BioPortfolio Logo
KeyNeurotek AG announces exclusive licence agreement with Bayer 1st January, 1970 Keyneurotek
KeyNeurotek AG announces exclusive licence agreement with Bayer Health-care AG June 29th, 2005: Magdeburg, Germany | Leverkusen, Germany – KeyNeurotek AG, a

BioNews Results for KeyNeurotek AG:

Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 4:27AM Matching: ag
Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 4:26AM Matching: ag
More middle-age women having heart attacks, but survival rates increasing
American Medical News:  Nov 16 2009 2:56AM Matching: ag
Quantities of Seasonal Flu Vaccine Diminishing in Kentucky
USAgNet:  Nov 15 2009 4:40AM Matching: ag
Rates of hospitalisation for acute respiratory illness and the emergence of pandemic (H1N1) 2009 virus in the
The Medical Journal of Australia:  Nov 15 2009 2:17PM Matching: ag
Promote your company here: BioNewsCast - Press Release Distribution

View more KeyNeurotek AG news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 569 times since April 2007, the link to the organisation's website has been followed 99 times

Recent Search Terms used to find this page: keyneurotek 2009 | Keyneurotek 2009 | AG Zenit download | KeyNeurotek | KeyNeurotek | GERMANY DVC leads EUR 8m round in KeyNeurotek Pharmaceuticals AG | GERMANY DVC leads EUR 8m round in KeyNeurotek Pharmaceuticals AG | keyneurotek | ag zenit download | KeyNeurotek | .

Search for more companies in Magdeburg

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for KeyNeurotek AG

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.